A Multi-layer Molecular Fresco of the Immune Diversity across Hematologic Malignancies

被引:3
作者
Bedognetti, Davide [1 ,2 ]
机构
[1] Sidra Med, Dept Canc Res, Doha, Qatar
[2] Univ Genoa, Dept Internal Med & Med Specialties, Genoa, Italy
关键词
D O I
10.1016/j.ccell.2020.08.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immune checkpoint blockade has limited activity in the large majority of hematologic malignancies. In this issue of Cancer Cell, Dufva et al. provide an immunologic portrait of these heterogenous diseases and identify key relationships between oncogenic states and immune response that can spur the development of more efficient immunotherapeutic approaches.
引用
收藏
页码:313 / 316
页数:5
相关论文
共 10 条
  • [1] Evolution of Metastases in Space and Time under Immune Selection
    Angelova, Mihaela
    Mlecnik, Bernhard
    Vasaturo, Angela
    Bindea, Gabriela
    Fredriksen, Tessa
    Lafontaine, Lucie
    Buttard, Benedicte
    Morgand, Erwan
    Bruni, Daniela
    Jouret-Mourin, Anne
    Hubert, Catherine
    Kartheuser, Alex
    Humblet, Yves
    Ceccarelli, Michele
    Syed, Najeeb
    Marincola, Francesco M.
    Bedognetti, Davide
    Van den Eynde, Marc
    Galon, Jerome
    [J]. CELL, 2018, 175 (03) : 751 - +
  • [2] Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
    Bedognetti, Davide
    Ceccarelli, Michele
    Galluzzi, Lorenzo
    Lu, Rongze
    Palucka, Karolina
    Samayoa, Josue
    Spranger, Stefani
    Warren, Sarah
    Wong, Kwok-Kin
    Ziv, Elad
    Chowell, Diego
    Coussens, Lisa M.
    De Carvalho, Daniel D.
    DeNardo, David G.
    Galon, Jerome
    Kaufman, Howard L.
    Kirchhoff, Tomas
    Lotze, Michael T.
    Luke, Jason J.
    Minn, Andy J.
    Politi, Katerina
    Shultz, Leonard D.
    Simon, Richard
    Thorsson, Vesteinn
    Weidhaas, Joanne B.
    Ascierto, Maria Libera
    Ascierto, Paolo Antonio
    Barnes, James M.
    Barsan, Valentin
    Bommareddy, Praveen K.
    Bot, Adrian
    Church, Sarah E.
    Ciliberto, Gennaro
    De Maria, Andrea
    Draganov, Dobrin
    Ho, Winson S.
    McGee, Heather M.
    Monette, Anne
    Murphy, Joseph F.
    Nistico, Paola
    Park, Wungki
    Patel, Maulik
    Quigley, Michael
    Radvanyi, Laszlo
    Raftopoulos, Harry
    Rudqvist, Nils-Petter
    Snyder, Alexandra
    Sweis, Randy F.
    Valpione, Sara
    Butterfield, Lisa H.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [3] Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
    Daver, Naval
    Garcia-Manero, Guillermo
    Basu, Sreyashi
    Boddu, Prajwal C.
    Alfayez, Mansour
    Cortes, Jorge E.
    Konopleva, Marina
    Ravandi-Kashani, Farhad
    Jabbour, Elias
    Kadia, Tapan
    Nogueras-Gonzalez, Graciela M.
    Ning, Jing
    Pemmaraju, Naveen
    DiNardo, Courtney D.
    Andreeff, Michael
    Pierce, Sherry A.
    Gordon, Tauna
    Kornblau, Steven M.
    Flores, Wilmer
    Alhamal, Zainab
    Bueso-Ramos, Carlos
    Jorgensen, Jeffrey L.
    Patel, Keyur P.
    Blando, Jorge
    Allison, James P.
    Sharma, Padmanee
    Kantarjian, Hagop
    [J]. CANCER DISCOVERY, 2019, 9 (03) : 370 - 383
  • [4] Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
    Dong, Zhong-Yi
    Zhong, Wen-Zhao
    Zhang, Xu-Chao
    Su, Jian
    Xie, Zhi
    Liu, Si-Yang
    Tu, Hai-Yan
    Chen, Hua-Jun
    Sun, Yue-Li
    Zhou, Qing
    Yang, Jin-Ji
    Yang, Xue-Ning
    Lin, Jia-Xin
    Yan, Hong-Hong
    Zhai, Hao-Ran
    Yan, Li-Xu
    Liao, Ri-Qiang
    Wu, Si-Pei
    Wu, Yi-Long
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (12) : 3012 - 3024
  • [5] Dufva O, 2020, CANCER CELL, V38, P380, DOI 10.1016/j.ccell.2020.06.002
  • [6] CRISPR TREATMENT INSERTED DIRECTLY INTO BODY FOR THE FIRST TIME
    Ledford, Heidi
    [J]. NATURE, 2020, 579 (7798) : 185 - 185
  • [7] Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens
    Malekzadeh, Parisa
    Yossef, Rami
    Cafri, Gal
    Paria, Biman C.
    Lowery, Frank J.
    Jafferji, Mohammad
    Good, Meghan L.
    Sachs, Abraham
    Copeland, Amyr.
    Kim, Sanghyun P.
    Kivitz, Scott
    Parkhurst, Maria R.
    Robbins, Paul F.
    Ray, Satyajit
    Xi, Liqiang
    Raffeld, Mark
    Yu, Zhiya
    Restifo, Nicholas P.
    Somerville, Robert P. T.
    Rosenberg, Steven A.
    Deniger, Drew C.
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (06) : 1267 - 1276
  • [8] Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response
    Roelands, Jessica
    Hendrickx, Wouter
    Zoppoli, Gabriele
    Mall, Raghvendra
    Saad, Mohamad
    Halliwill, Kyle
    Curigliano, Giuseppe
    Rinchai, Darawan
    Decock, Julie
    Delogu, Lucia G.
    Turan, Tolga
    Samayoa, Josue
    Chouchane, Lotfi
    Ballestrero, Alberto
    Wang, Ena
    Finetti, Pascal
    Bertucci, Francois
    Miller, Lance D.
    Galon, Jerome
    Marincola, Francesco M.
    Kuppen, Peter J. K.
    Ceccarelli, Michele
    Bedognetti, Davide
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [9] Thorsson V, 2019, IMMUNITY, V51, P411, DOI [10.1016/j.immuni.2019.08.004, 10.1016/j.immuni.2018.03.023]
  • [10] Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia
    Vadakekolathu, Jayakumar
    Minden, Mark D.
    Hood, Tressa
    Church, Sarah E.
    Reeder, Stephen
    Altmann, Heidi
    Sullivan, Amy H.
    Viboch, Elena J.
    Patel, Tasleema
    Ibrahimova, Narmin
    Warren, Sarah E.
    Arruda, Andrea
    Liang, Yan
    Smith, Thomas H.
    Foulds, Gemma A.
    Bailey, Michael D.
    Gowen-MacDonald, James
    Muth, John
    Schmitz, Marc
    Cesano, Alessandra
    Pockley, A. Graham
    Valk, Peter J. M.
    Lowenberg, Bob
    Bornhaeuser, Martin
    Tasian, Sarah K.
    Rettig, Michael P.
    Davidson-Moncada, Jan K.
    DiPersio, John F.
    Rutella, Sergio
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (546)